All News
RheumNow’s expanded coverage of the #EULAR2025 Annual meeting is sponsored in part by Johnson & Johnson and UCB. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
#EULAR2025 Abstr#LB0005 Phase IIb RCT in moderate #Sjogren reported significant reduction in ESSDAI at WK24 from BL in HCQ-Leflunomide vs PBO. CRESS & STAR improved. No significant difference in UWS, Schirmer, & ESSPRI. Future work: cohort of high symptom burden @RheumNow
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
The transformative potential of integrating ePROMs into AI care pathways
🔺️Study by Dr Antoni Chan et al. achieved a new-to-followup ratio of 1:2.5 outperforming the national average of 1:4.2
🔺️Without losing contact with pts
@synovialjoints
POS1271
#EULAR2025
@RheumNow https://t.co/z3jO3ADHR1
Nelly ZIADE 🍀 Nellziade ( View Tweet)
Why do Rheumatologists shift to private practice? Are there gender based differences?
A survey of 100+ European rheumatologists
Female 🚺 rheumatologists:
Leave hospital earlier
At a lower hierarchical level
Reasons for leaving:
nightshifts
unfair promotion decisions
Aurelie Najm AurelieRheumo ( View Tweet)
EULAR PtC for definition of #TR Trt Refractory) #Psoriatic_Arthritis
#D2M
1️⃣ Failure >= 2 b/tsDMARDs
2️⃣ Problematic
3️⃣ Evidence of persistent dis
+
4️⃣ Exclude drivers like comorbidities & psychosocial factors
🔺️Exclude failure due to Side Effets/CI
#EULAR2025
@RheumNow https://t.co/ULD2Xe6p6A
Nelly ZIADE 🍀 Nellziade ( View Tweet)
Imagine #Barcelona with an additional 8 degrees in summer 🔥 🔥🔥
Session: Disaster Medicine - Impact of climate change, heat, and global insecurity
#EULAR2025
@RheumNow https://t.co/1TqlBJtoZD
Nelly ZIADE 🍀 Nellziade ( View Tweet)
RA is worst with temperature rising/ climate change.
However SpA has the opposite effect!
Climate change session at #EULAR2025 @RheumNow https://t.co/eKVXnfdEzD
Bella Mehta bella_mehta ( View Tweet)
Genicular artery embolisation is like so many interventions in MSK medicine:
early promise with smaller RCT & observational data, but the later, more robust data doesn’t show the same benefit.
If you do meta-analyses of all these data, you mix good with bad
#EULAR2025 @RheumNow https://t.co/K1tN9KX8rq
David Liew drdavidliew ( View Tweet)
Social disparities in rheumatology @RheumNow #EULAR2025
~70% of outcomes are determined by Social determinants of health
Modifiable factors ? Maybe? https://t.co/UfC2nQ5Azy
Bella Mehta bella_mehta ( View Tweet)
@RheumNow Achieving health equity is the goal
1.4% of GDP is lost in health inequity in EU https://t.co/50M4SfuxvX
Bella Mehta bella_mehta ( View Tweet)
How much of the health outcomes are related to social determinants?
🔺️Up to 75%!
Disaster Medicine Session
Social disparities and impact on outcomes
Dr Kate Webb
#EULAR2025
@RheumNow https://t.co/0Ahbf79Nbx
Nelly ZIADE 🍀 Nellziade ( View Tweet)
#EULAR2025 Abstr#LB0007 Two’s Company, Three’s a Crowd! In 5 #SLE pts treated with CC312, a novel CD19/CD3/CD28 tri-specific ab in dose escalation showed rapid & B-cell depletion & all achieved SRI-4. No =>G2 CRS or ICANS. USP: off-the-shelf & overcome T-cell exhaustion @RheumNow https://t.co/6DZRj09JEQ
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Low disease activity more difficult to achieve in vulnerable populations.
All rheumatic diseases - #RA #PsA #AS
initiating DMARDs takes longer in these population
#EULAR2025 @RheumNow https://t.co/voIivshKRt
Bella Mehta bella_mehta ( View Tweet)
What do we know about disparities in #SLE
- worse in women
- worse in non white populations
- have lower quality of care in vulnerable populations
- have worse outcomes in vulnerable populations
#EULAR2025 @rheumnow
Diagnosis itself is difficult in communities with poor access https://t.co/pcUaJ0eK65
Bella Mehta bella_mehta ( View Tweet)
#Lupus is one of the biggest social discriminators
🔺️Higher prevalence in Women
🔺️Higher prevalence in Non-Whites
🔺️More catastrophic manifestations in low socioeconomic groups
Disaster Medicine Session
Social disparities and impact on outcomes
#EULAR2025
@RheumNow https://t.co/mewR9NzXHt
Nelly ZIADE 🍀 Nellziade ( View Tweet)
Migrant health literacy challenges - Individual interviews with participants with rheumatic diseases (interpreters used)
multiple aspects -
Individual, Providers and system level
Navigating health care systems
#EULAR2025 @RheumNow https://t.co/cWQ6jP8RZe
Bella Mehta bella_mehta ( View Tweet)
It’s a hot topic at #EULAR2025, but the messages on AI in medicine from patient-professional discussions is clear:
- potential upside massive in many domains, but
- patients still want their clinicians by their side
#EULAR2025 meeting highlights @RheumNow https://t.co/4T6gE7TeQp
David Liew drdavidliew ( View Tweet)
Great talk by @Lupusreference on Relapsing Polychondritis and a highlight of #EULAR2025. Do not forget about the articular presentations of relapsing polychondritis @RheumNow https://t.co/1xZY7VkX1z
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
EULAR Classification criteria for hemachromatosis, presented by Prof. Kiely shows clinical pearls in diagnosis - Hook osteophytes @MCP 2/3, & Iron Fist sign w/ elevation of MCPs 2&3. #EULAR2025 https://t.co/S8iA0C4pwG
Dr. John Cush RheumNow ( View Tweet)
EULAR 2025 - Day 1 Report
Wednesday was Day One at EULAR 2025 in Barcelona. Thousands from around the world gathered, eager to reunite at this international educational forum. Below are a few of my favorites from Day 1.
https://t.co/ycQT2dfVXe https://t.co/Qa58ofW411
Dr. John Cush RheumNow ( View Tweet)
